Tolerability profile consistent with the incretin class, with gastrointestinal events most commonly reported in studies (e.g., nausea, diarrhoea, and constipation)
For individuals participating in retatrutide clinical trials, or for those following developments in this area ahead of potential future approval, understanding how to manage GI side effects is important
Type 2 diabetes Treatment summaries, BNF
This is currently used for surgical site infiltration, and rigorous preclinical modeling is required to assess the safety of liposomal particles within the dural microvasculature to ensure they do not induce inadvertent complications
Weight loss and sermorelin Peptide treatments such as GLP-1 medications for weight loss have exploded in availability, and sermorelin and similar peptides are right behind them